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Escherichia coli F-18 Col- was previously shown to be a poor colonizer of the streptomycin-treated mouse
large intestine, relative to its parent, E. coli F-18. Prior to attempting to clone genes responsible for the
colonization phenotype of E. coli F-18 into E. coli F-18 Col-, a suitable cloning vector had to be found. In this
investigation, we report that the commonly used cloning vectors pBR322, pHC79, and pBR329 all segregate
from E. coli F-18 Col- both when grown in L broth under conditions of nonselection (i.e., in vitro) and when
fed to streptomycin-treated mice (i.e., in vivo). Insertion of the cer region (which promotes resolution of
replicating plasmids into monomeric forms) into pHC79 stabilized this plasmid in E. coli F-18 Col- in vitro and
in vivo. In contrast, two independent cer insertions into pBR329 did not stabilize the plasmid completely in E.
coli F-18 Col- in vitro, and feeding the strain to streptomycin-treated mice resulted in rapid segregation of the
plasmids in vivo. Also, stability of all three plasmids in E. coli F-18 Col- in vitro was achieved by insertion of
theparB region of plasmid Rl, which encodes a cell-killing protein, Hok, that is active only postsegregationally.
However, as with cer, complete in vitro and in vivo stabilization was achieved only in parB constructs of
pBR322 and pHC79.
Escherichia coli F-18, isolated from the feces of a healthy
person in 1977, is an excellent colonizer of the streptomycin-
treated mouse large intestine (5). E. coli F-18 Col-, a
derivative of E. coli F-18, colonizes the streptomycin-treated
mouse large intestine as well as its parent does when either
is fed to mice alone, but it is unable to colonize when fed to
mice together with the parent strain because of the inability
of E. coli F-18 Col- to grow in cecal mucus in the presence
of E. coli F-18 (20). Furthermore, when streptomycin-
treated mice are simultaneously fed 108 CFU of E. coli F-18
Col- and only 103 CFU of E. coli F-18, E. coli F-18 becomes
the predominant strain in the mouse large intestine within a
few days (20). These data suggested the possibility of shot-
gun-cloning genes from E. coli F-18 into E. coli F-18 Col-
and the subsequent selection by the mouse intestine of those
clones that contain the functional E. coli F-18 colonization
gene(s) that are defective or missing in E. coli F-18 Col-.
However, prior to cloning, a suitable highly stable vector
(i.e., one which would not segregate in vivo) had to be
chosen to carry these putative colonization genes. Here we
present evidence that several commonly used cloning vec-
tors are unstable in E. coli F-18 Col- both in vitro and in
vivo and that insertion of either of the stabilizing loci cer or
parB into these vectors can enhance the stability of these
plasmids significantly.
MATERIALS AND METHODS
Bacterial strains. A spontaneous double mutant of E. coli
HB101 (4) resistant to both streptomycin sulfate (Strr) and
nalidixic acid (NalP) was used for the isolation and charac-
terization of relevant constructions. E. coli F-18 Col-, used
for all plasmid stability assays reported here, was originally
isolated (5) as follows. A streptomycin-resistant, nalidixic
acid-resistant mutant of E. coli F-18 was mated with E. coli
RS2, which contains the Rldrdl9 plasmid (R1+), and an E.
* Corresponding author.
coli F-18 R1+ strain was isolated. The E. coli F-18 R1+ strain
was cured of the Rldrdl9 plasmid with acriflavin. One of the
cured clones, E. coli F-18 Col-, lost both a 3 x 107-dalton
plasmid and the ability to make the F-18 colicin (5).
Media. The bacterial growth medium for all strains was L
broth (2). The plating medium for both the in vitro and in
vivo stability assays was MacConkey agar (Difco Laborato-
ries, Detroit, Mich.) with additional antibiotics as needed:
streptomycin sulfate, nalidixic acid, tetracycline hydrochlo-
ride, kanamycin monosulfate, ampicillin, and chloramphen-
icol at concentrations of 100, 50, 10, 40, 100, and 40 ,ug/ml,
respectively.
Bacterial transformation. Both E. coli HB101 (Strr Nal')
and E. coli F-18 Col- (Strr Nalr) were made competent and
transformed with plasmid DNA by the method of Mandel
and Higa (14).
Biochemical and recombinant DNA techniques. Small-scale
preparations of plasmid DNA were done by the method of
Bimboim and Doly (3). Agarose gel electrophoretic analysis
of restriction fragments was carried out with 1.5% agarose
for detection of fragments of less than 500 base pairs and
0.8% agarose for all other applications. Ligation and restric-
tion endonuclease reactions were done essentially as de-
scribed by the manufacturer (Bethesda Research Laborato-
ries, Gaithersburg, Md.). Calf intestinal phosphatase
treatments were done essentially as described by the manu-
facturer (Boehringer Mannheim Biochemicals, Indianapolis,
Ind.), and all restriction fragment purifications were per-
formed with GENECLEAN according to the instructions
provided by the manufacturer (Bio 101 Inc., La Jolla, Calif.).
Plasmid constructions. Plasmids used in this study are
listed in Table 1. pRLB1 is a cosmid construct originating
from a BamHI-HindIII digest of pKS492 (18). The resulting
280-base-pair fragment, containing cer, was treated with
GENECLEAN and ligated to a phosphatase-treated BamHI-
HindIII digest of pHC79 (12). pRLB2 is a cosmid construct
derived from an EcoRI-BamHI digest of pPR633 (9), which
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TABLE 1. Properties of plasmids used and constructed
Plasmid Replicon Characteristicsa Locationb Reference
pBR322 pMB1 bla tet - 1
pHC79 pBR322 bla tet cos - 12
pBR329 pBR322 bla tet cat - 6
pJBK5 ColEl tet cat - 13
pPR633 pBR322 bla parB 0 to +580 11
pRLB1 pBR322 bla cer +30 to +328 This article
pRLB2 pBR322 bla parB 0 to +598 This article
pRLB3 pBR322 bla tet cer +102 to +1,102 This article
pRLB4 pBR322 bla tet cer + 102 to +1,102 This article
pRLB5 ColEl tet cat This article
pRLB6 pBR322 tet cat aphA parB +2,750 to +4,380 This article
a aphA, Kanamycin resistance; bla, ampicillin resistance; tet, tetracycline resistance; cat, chloramphenicol resistance; cos, cohesive ends.
b Location of stability determinant, in base pairs, for all constructions. For all plasmids for which a coordinate location is given, the reference point (0 base
pair) is the EcoRI site.
produces a 580-base-pair fragment containing parB, and
subsequently ligated to analogously cleaved and phos-
phatase-treated pHC79 molecules. pRLB3 and pRLB4 rep-
resent two promoter orientations of ColEl resolution con-
taining pBR329 derivatives. These plasmids were generated
by cloning a 1.0-kilobase (kb) PvuII fragment of pKS492
containing cer into the single PvuII site of pBR329 (6).
pRLB5 was constructed from a GENECLEAN-purified 1.0-
kb fragment of an MluI digest of lambda DNA cloned into
the single phosphatase-treated MluI site of pJBK5, presum-
ably interrupting cer function (13). pRLB6 is a kanamycin
monosulfate-resistant pBR329 derivative constructed by
cloning the 1.6-kb PstI fragment of pKG1022, containing
parB and the aphA gene (8), into the single PstI site of
pBR329.
In vivo segregation assays. The method for in vivo segre-
gations was the same as that used to distinguish between the
relative colonizing abilities of E. coli strains in mice and was
described in detail previously (5, 20). Briefly, three 5- to
8-week-old CD-1 mice were given drinking water containing
5 g of streptomycin sulfate per liter. After 1 day, the mice
were starved for 16 to 24 h for water and food (Charles River
Valley Rat, Mouse and Hamster Formula) and then fed 1010
CFU of an L broth-grown, plasmid-containing E. coli F-18
Col- strain suspended in 1 ml of sterile 20% (wt/vol) sucrose
solution. After consuming the bacterial suspension, the mice
were returned to a diet of food and streptomycin-containing
water. The following day and at 48-h intervals thereafter, 1 g
of feces no older than 24 h from each of three mice was
collected, suspended, homogenized, diluted, and plated on
selective media to differentiate between plasmid-bearing and
plasmid-free cells, as described previously (5). In all exper-
iments reported here, plates were incubated at 37°C for 16 to
24 h. Plasmid stability was assessed by the level at which
plasmid-bearing cells of strain E. coli F-18 Col- persisted in
feces. Assays were performed at least twice, with essentially
identical results.
In vitro segregation assays. Initially, plasmid-containing E.
coli F-18 Col- cells were inoculated into tubes containing 5
ml of L broth with either 100 ,ug of ampicillin per ml or 10 ,ug
of tetracycline per ml, as required. Cultures were grown to
stationary phase (standing) and serially diluted 106-fold into
5 ml of L broth (no antibiotics added). This dilution, repre-
senting approximately 103 CFU/ml, was regrown overnight
at 37°C, serially diluted, and plated onto selective media to
distinguish between plasmid-containing and plasmid-free
cells. Sequential 106-fold dilutions were regrown to station-
ary phase every 24 h for a total of 11 days. Each 24-h cycle
represents approximately 20 generations of growth, for a
total of about 220 generations per strain.
Statistics. Where indicated in the text, means derived from
triplicate samples were compared by using Student's t test (P
values).
RESULTS
pBR322. pBR322, a 4.3-kb, ColEl-relaxed replicon, is a
standard cloning vector used in numerous cloning and
expression applications in molecular biology (1). pBR322 is
well documented, and its entire nucleotide sequence has
been elucidated (19). The plasmid has a copy number of
about 18 per genome under steady-state conditions in E. coli
K-12 strains (7). pBR322 segregated readily from E. coli F-18
Col- both in vitro, so that after about 220 generations only
about 1 of 600 cells contained the plasmid (Table 2), and in
vivo, so that by day 7 postfeeding only about 1 of 104 cells
contained the plasmid (Fig. 1A). However, pPR633, which
contains parB inserted into pBR322 (9), was completely
stable in E. coli F-18 Col- both in vitro (Table 2) and in vivo
(Fig. 1B).
pHC79. pHC79 is a cosmid derivative of pBR322 made
from a pBR322 Saul-induced rearrangement, which has a
single BglII site (pJC80, 2.95 megadaltons) located between
the end of the tetracycline gene and the origin of replication.
A 1.1-megadalton BglII fragment containing the cos site
TABLE 2. In vitro plasmid segregation from E. coli F-18 Col-
Ratio of total CFU/ml to plasmid-containing
CFU/ml after:
Plasmid
20 140 220
generations generations generations
pBR322 1.02 39.5 618
pPR633 1.04 1.02 1.02
pHC79 1.59 88.9 1,778
pRLB1 0.91 1.14 0.91
pRLB2 0.89 0.89 1.00
pBR329 1.07 11.90 105
pRLB3 0.83 1.25 3.38
pRLB4 1.14 1.19 3.39
pRLB6 1.25 0.98 3.25a
a This ratio was confirmed by transferring (with toothpicks) 55 colonies
from plates containing streptomycin and nalidixic acid (total CFU plates) to
plates containing streptomycin, nalidixic acid, and kanamycin in order to
score pRLB6-containing (kanamycin-resistant) CFU and pRLB6-free (kan-
amycin-sensitive) CFU.
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from lambda Charon 3A was cloned into that unique site,
allowing for in vitro packaging of large sequences of foreign
DNA into lambda bacteriophage capsids (12). pHC79 be-
haved similarly to pBR322 in that pHC79 segregated rapidly
from E. coli F-18 Col- both in in vitro (Table 2) and in vivo
(Fig. 2A). Insertion of either cer, to yield pRLB1, orparB, to
yield pRLB2, completely stabilized this plasmid in E. coli
F-18 Col- both in vitro (Table 2) and in vivo (Fig. 2B and C).
pBR329. pBR329 is a high-copy number variant of
pBR322, i.e., 30 copies per genome in E. coli K-12 strains
(15). The plasmid is a 4.15-kb hybrid construct of pBR327
and pBR328 made from an HhaI digest of pBR328 (carrying
the chloramphenicol resistance gene) treated with BalI exo-
nuclease. The resulting fragments were ligated to an Si
nuclease-treated EcoRI site of pBR327 (6). pBR329 segre-
gated from E. coli F-18 Col- both in vitro (Table 2) and in
vivo (Fig. 3A). Although two independent cer insertions (to
yield pBRL3 and pBRL4) significantly stabilized pBR329 in
vitro (Table 2), neither construct had an effect on the rapid
rate of segregation in vivo (Fig. 3B; one construct, pBRL3,
is shown). Similarly, insertion of the parB region of plasmid
Rl into pBR329 (to yield pBRL6) stabilized pBR329 to a
great extent in E. coli F-18 Col- in vitro (Table 2); however,
in vivo (Fig. 3C), the addition of parB still resulted in
plasmid segregation.
pJBK5. During the course of this work, pJBK5, a ColEl
derivative (13), was tested in E. coli F-18 Col- for its
segregation rate in vivo and was found to be stable (Fig. 4A).
Since the original ColEl plasmid contains the cer region,
which has a unique MluI site (18), pJBK5 was restricted with
MluI and a small piece of bacteriophage lambda DNA was
inserted to disrupt the cer function (see Materials and
Methods). The resulting construct, pRLB5, was subse-
quently transformed into E. coli F-18 Col- and found to
segregate rapidly in vivo (Fig. 4B). These data indicate that
pJBK5 stabilization is most likely caused by cer function.
DISCUSSION
The commonly used cloning vectors pBR322, pHC79, and
pBR329 were all found to be unstable in E. coli F-18 Col-
both in vitro and in vivo (Table 2 and Fig. 1A, 2A, and 3A).
Insertion of the cer region, a site-specific recombination
sequence which promotes conversion of plasmid multimers
(which occur through recA-dependent homologous recombi-
nation) to monomers, in conjunction with the trans-acting
chromosomally encoded xerA gene product (16), has been
shown previously to stabilize plasmids in vitro (17). In our
hands, cer prevented segregation of pHC79 completely both
in vitro and in vivo (Table 2 and Fig. 2B). A pBR322 cer
plasmid was not constructed because it is closely related to
pHC79. Two distinct cer promoter orientation constructions
of pBR329 stabilized the plasmid in vitro; however, between
generations 140 and 220, segregation in vitro was observed
(Table 2). Both constructs segregated rapidly in vivo (one is
shown in Fig. 3B).
As was observed for cer, the parB region of plasmid Rl
stabilized the plasmid in vitro i.e., pBR322 and pHC79 were
10
c09a)
u 6
58-
07-
a)
<0 7 -
O-
a-. 6 -
rzr- 5-
064.
a)
Z 2 -
0
0
1 2 3 4 5
Days
10
u _1-
1 4 7 10 13
Days
10
1 4 7 10
Days
FIG. 2. In vivo segregation of pHC79 from E. coli F-18 Col- (pHC79) (A), pRLB1 from E. coli F-18 Col- (pRLB1) (B), and pRLB2 from
E. coli F-18 Col- (pRLB2) (C). Symbols: 0, total CFU; A, plasmid-containing CFU.
10
B.
9 _
8
7 i f.,<i!
6-_
5-_
4-_
3-_
2-_
1
0 4
A.
T
I
B.
9
_
8
7
_41i<<i0 IA7
66 _
5 _
4 _
3 _
2 _
1 ll
A
C.
9 --
5-
4-
3-
2-
1
.IA
0 A
13
VOL. 58, 1990
 o
n
 August 17, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
1144 BURGHOFF ET AL.
10
C) (19
07
a)
PC,6
04
0 7a)
Z 2
0
u 1
04
10 10
v ,I ,v l
1 4 7 10 1 4 7 10 13 1 4 7 10
Days Days Days
FIG. 3. In vivo segregation of pBR329 from E. coli F-18 Col- (pBR329) (A), pRLB3 from E. coli F-18 Col- (pRLB3) (B), and pRLB6 from
E. coli F-18 Col- (pRLB6) (C). Symbols: 0, total CFU; A, plasmid-containing CFU.
stabilized completely, and pBR329 showed reduced segre-
gation in E. coli F-18 Col- (Table 2). As with cer, parB
stabilized pBR322 and pHC79 in vivo but was unable to
stabilize pBR329 in vivo (Fig. 3C). This is somewhat sur-
prising, since segregation of a plasmid containing the parB
region is supposed to result in postsegregational killing of the
plasmid-free cell (11). That is, the cell-killing gene hok,
located within the parB region, encodes a 52-amino-acid
protein which causes collapse of transmembrane potential
(9). In plasmid-containing cells, hok expression is prevented
by an antisense RNA, sok, which is also encoded within the
parB region. The antisense RNA forms an RNA-RNA hy-
brid with the hok transcript inhibiting translation. Segrega-
tion of a parB-containing plasmid leads to a rapid degrada-
tion of sok RNA, leaving hok mRNA free for translation of
the 52-amino-acid product, which kills the plasmid-free cells
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FIG. 4. In vivo segregation of pJBK5 from E. coli F-18 Col-
(pJBK5) (A) and pRLB5 from E. coli F-18 Col- (pRLB5) (B).
Symbols: 0, total CFU; A, plasmid-containing CFU.
(10). Therefore, the parB region ensures that all live bacterial
cells contain the plasmid. Apparently, some E. coli F-18
Col- cells which segregate the pBR329 derivative containing
parB escape death in vivo and efficiently colonize the
streptomycin-treated mouse large intestine. Although we do
not understand why pBR329 containing cer and parB segre-
gates slowly in vitro and rapidly in vivo, the fact that it does
underscores the idea that even the most stable plasmids in
vitro should be tested for segregational stability in vivo. In
any case, plasmids pPR633, pRLB1, and pRLB2 are stable
constructs and seem ideally suited for in vivo selection of
recombinant clones containing colonization genes.
ACKNOWLEDGMENTS
We gratefully acknowledge S0ren Molin for the donation of
pPR633 and pKG1022, David Sherratt for pKS492, Robert Kwiat-
kowski for plasmid pBR329, and James Kaper for plasmid pJBK5.
We also thank Nikolaus Schlaich and D. Mac Richardson for expert
technical assistance and Ruth Vilardofsky and Carolyn Lunt for
their help in preparing the manuscript.
This research was supported by Public Health Service grant
A116370 to P.S.C. and D.C.L. from the National Institute of Allergy
and Infectious Diseases and by a grant-in-aid of research awarded to
R.L.B. from Sigma Xi.
LITERATURE CITED
1. Balbas, P., X. Soberon, E. Merino, M. Zurita, H. Lomeli, F.
Valie, N. Flores, and F. Bolivar. 1986. Plasmid vector pBR322
and its special derivatives-a review. Gene 50:3-40.
2. Bertani, G. 1951. Studies on lysogenesis. I. The mode of phage
liberation by lysogenic Escherichia coli. J. Bacteriol. 62:293-
300.
3. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction
procedure for screening recombinant plasmid DNA. Nucleic
Acids Res. 7:1513-1523.
4. Boyer, H. W., and D. Roulland-Dussoix. 1969. A complementa-
tion analysis of the restriction and modification of the DNA in
Escherichia coli. J. Mol. Biol. 41:459-472.
5. Cohen, P. A., R. Rossoll, V. J. Cabelli, S.-L. Yang, and D. C.
Laux. 1983. Relationship between the mouse colonizing ability
of a human fecal Escherichia coli strain and its ability to bind a
specific mouse colonic mucous gel protein. Infect. Immun.
40:62-69.
6. Covarrubias, L., and F. Bolivar. 1982. Construction and char-
B.
8 1
1 NI i *\
8 -- l a -I- -,
7 i
6 - \
2 IIll
1
I\
C.
9
8-
7T
6~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
A
4-T
A
3-1
2-
1
A.
7-tT
B.
9
8-_
7- _
6-
5-
4
3 \T
2 -_
1
n
INFECT. IMMUN.
 o
n
 August 17, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
STABLE CLONING VECTORS 1145
acterization of new cloning vehicles. VI. Plasmid pBR329, a
new derivative of pBR328 lacking the 482-base pair inverted
duplication. Gene 17:79-89.
7. Covarrubias, L., L. Cerventes, A. Covarrubias, X. Soberon, I.
Vichido, A. Blanco, Y. M. Kuperstoch-Portnoy, and F. Bolivar.
1981. Construction and characterization of new cloning vehi-
cles. V. Mobilization and coding properties of pBR322 and
several deletion derivatives including pBR327 and pBR328.
Gene 13:25-35.
8. Gerdes, K. 1988. The parB (hoklsok) locus of plasmid RI: a
general purpose plasmid stabilization system. Biotechnology
6:1402-1405.
9. Gerdes, K., F. W. Beck, S. T. Jorgensen, A. Lobner-Olesen,
P. B. Rasmussen, T. Atlung, 0. Karistrom, S. Molin, and K. von
Meyenburg. 1986. Mechanisms of postsegregational killing by
the hok gene product of the parB system of plasmid Rl and its
homology with the relF gene product of the E. coli relB operon.
EMBO J. 5:2023-2029.
10. Gerdes, K., K. Helin, 0. W. Wiborg, and A. Lobner-Olesen.
1988. Translational control and differential RNA decay are key
elements regulating postsegregational expression of the killer
protein encoded by the parB locus of plasmid Rl. J. Mol. Biol.
203:119-129.
11. Gerdes, K., P. R. Rasmussen, and S. Molin. 1986. Unique type
of plasmid maintenance function: postsegregational killing of
plasmid-free cells. Proc. Natl. Acad. Sci. USA 83:3116-3120.
12. Hohn, B., and J. Collins. 1980. A small cosmid for the efficient
cloning of large DNA fragments. Gene 11:291-298.
13. Levine, M. M., J. B. Kaper, H. Lockman, R. E. Black, M. L.
Clements, and S. Falkow. 1983. Recombinant DNA risk assess-
ment studies in humans: efficacy of poorly mobilizable plasmids
in biological containment. J. Infect. Dis. 148:699-709.
14. Mandel, M., and A. Higa. 1970. Calcium-dependent bacterio-
phage DNA infection. J. Mol. Biol. 53:159-164.
15. Soberon, X., L. Covarrubias, and F. Bolivar. 1980. Construction
and characterization of new cloning vehicles. IV. Deletion
derivatives of pBR322 and pBR325. Gene 9:287-305.
16. Stirling, C. J., G. Szatmari, G. Stewart, M. C. M. Smith, and
D. J. Sherratt. 1988. The arginine repressor is essential for
plasmid-stabilizing site-specific recombination at the ColEl cer
locus. EMBO J. 7:4389-4395.
17. Summers, D. K., and D. J. Sherratt. 1984. Multimerization of
high copy number plasmids causes instability: ColEl encodes a
determinant essential for plasmid monomerization and stability.
Cell 36:1097-1103.
18. Summers, D. K., and D. J. Sherratt. 1988. Resolution of ColEl
dimers requires a DNA sequence implicated in the three-
dimensional organization of the cer site. EMBO J. 7:851-858.
19. Sutcliffe, J. G. 1979. Complete nucleotide sequence of the E.
coli plasmid pBR322. Cold Spring Harbor Symp. Quant. Biol.
43:77-80.
20. Wadolkowski, E. A., D. C. Laux, and P. S. Cohen. 1988.
Colonization of the streptomycin-treated mouse large intestine
by a human fecal Escherichia coli strain: role of growth in
mucus. Infect. Immun. 56:1030-1035.
VOL. 58, 1990
 o
n
 August 17, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
